Burning Rock Biotech Ltd.-ADRBNR
13F holders, Q4 2025 (December 31)16holders
3new positions
3sold out
1famous investor
$20.43avg. 13F price*
At the end of Q4 2025, 16 institutions reported holding Burning Rock Biotech Ltd.-ADR (BNR) in their 13F filings, unchanged from Q3 2025. 3 opened new positions and 3 sold out. The largest holders were Kynam Capital Management, LP ($20.0M), CRCM LP ($9.9M) and HSG Holding Ltd ($871K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Burning Rock Biotech Ltd.-ADR
- CUSIP
- 12233L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $623K |
| Exits | 3 | $114K |
All 13F filers, Q3 2025 → Q4 2025: 309,408 shares bought and 30,161 shares sold, net +279,247 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Kynam Capital Management, LP | 1.31% | No change | 994,883 | $20.0M |
| CRCM LP | 3.35% | Add +121.8% | 491,426 | $9.9M |
| HSG Holding Ltd | 0.05% | No change | 21,212 | $871K |
| Amova Asset Management Americas, Inc. | 0.01% | Reduce -8.7% | 31,807 | $652K |
| Sumitomo Mitsui Trust Group, Inc. | 0.00% | Reduce -8.7% | 31,807 | $641K |
| Prospera Financial Services Inc | 0.01% | Add +26.0% | 31,185 | $628K |
| Renaissance Technologies | 0.00% | Reduce -1.9% | 31,117 | $627K |
| Bank of America Corp. | 0.00% | No change | 29,178 | $588K |
| Redwood Wealth Management Group, LLC | 0.17% | New | 20,023 | $403K |
| Morgan Stanley | 0.00% | Reduce -46.8% | 11,840 | $239K |
| Marshall Wace, LLP | 0.00% | New | 10,903 | $220K |
| BNP Paribas Financial Markets | 0.00% | Add +211.1% | 2,800 | $56K |
| Shen Neil Nanpeng | 100.00% | No change | 885 | $36K |
| UBS Group AG | 0.00% | Add +34.6% | 1,168 | $24K |
| BlackRock, Inc. | 0.00% | No change | 10 | $202 |
| Citigroup Inc. | 0.00% | New | 1 | $20 |
"% of holder's portfolio" is BNR's weight in each manager's 13F, not the share of Burning Rock Biotech Ltd.-ADR the manager owns.